Theralase Technologies leads the way in light-activated cancer therapies
Positive releases have centred around its photodynamic therapy technology
Company
Theralase Technologies Inc
CVE:TLT
Theralase Technologies Inc is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations intended to safely and effectively destroy various cancers.
80 stories · page 2 of 4
Theralase Technologies receives go-ahead to expand its photodynamic technology into Chinese market
The biotech firm has been granted a 'Notice of Acceptance' by the Chinese patent office for its photoDynamic compounds
Theralase Technologies further bolstered as TLD-1433 shown to be effective against cervical cancer
The light activated compound has now been proven to be effective against cervical cancer.
Theralase Technologies sees 14% increase in half year revenue as it ramps up sales teams
The group's therapeutic laser technology (TLT) division is commercializing the next-generation TLC-2000 therapeutic medical laser system
Theralase Technologies lifted by positive independent scientific study of its anti-cancer drug range
"The clinical utility of PDC [photo dynamic compounds] super-catalysts cannot be understated, having the potential to overcome variations in light dosimetry and other issues that have prohibited the application of PDT [photo dynamic therapy